Intriguingly, in neuroblastoma, RUNX1 exhibits elevated expression levels in benign ganglioneuromas (GN) and well-differentiated tissues, while displaying reduced expression in poorly differentiated and undifferentiated tissues, suggesting its tumor-suppressive role in neuroblastoma [51]. This evidence concerns the gene RUNX1 and neoplasm.